Credit Suisse’s Genprex GNPX Stock Holding History

Credit Suisse’s Portfolio GNPX Stock Details GNPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2	Closed	-$270K	–	4060
2020 Q2	$270K	Buy	+2	New	+$245K	﹤0.01%	3631

Other funds holding GNPX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Credit Suisse's GNPX Position: Q3 2020 in Review

Credit Suisse sold out of Genprex (GNPX) in Q3 2020, closing a stake of 2 shares — an estimated $270K sold.

Credit Suisse first reported a position in GNPX in Q2 2020 and held it in 1 quarter. The position peaked at $270K in Q2 2020. 22 funds tracked by Wall St. Rank hold GNPX as of Q3 2020.

Credit Suisse reported no remaining Genprex position as of Q3 2020 after selling out during the quarter.
Credit Suisse sold 2 Genprex shares in Q3 2020, an estimated $270K.
Credit Suisse first reported a position in Genprex in Q2 2020 and held it in 1 quarter.
Credit Suisse's Genprex position peaked at $270K in Q2 2020.
22 funds tracked by Wall St. Rank held Genprex as of Q3 2020.

Based on Credit Suisse's 13F filing for Q3 2020, filed 13 Nov 2020.